Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib

Daniel J. Crona, Andrew D. Skol, Veli-Matti Leppänen, Dylan M. Glubb, Amy S. Etheridge, Eleanor Hilliard, Carol E. Pena, Yuri K. Peterson, Nancy Klauber-DeMore, Kari K. Alitalo, Federico Innocenti

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalCancer Research
Volume79
Issue number1
Pages (from-to)231-241
Number of pages11
ISSN0008-5472
DOIs
Publication statusPublished - 1 Jan 2019
MoE publication typeA1 Journal article-refereed

Fields of Science

  • FACTOR-TARGETED THERAPY
  • MULTIKINASE INHIBITOR
  • LIGAND-BINDING
  • GROWTH
  • CANCER
  • ANGIOGENESIS
  • ASSOCIATION
  • ACTIVATION
  • MECHANISMS
  • 3111 Biomedicine
  • 3122 Cancers

Cite this